Overview
- 4 inspections across 4 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-04-24.
At a glance
Inspections
4
Sites
4
Observations
0
Career since
Jun 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Replimune, Inc. | 24 Apr 2025 | Biologics | On file |
| Massbiologics South Coast | 12 Aug 2024 | Biologics | On file |
| Krystal Biotech, Inc. | 16 Nov 2022 | Biologics | On file |
| Catalent Maryland Inc | 19 Jun 2020 | Biologics | On file |
Sites inspected
Replimune, Inc.Woburn, United States1 insp.
Massbiologics South CoastFall River, United States1 insp.
Krystal Biotech, Inc.Pittsburgh, United States1 insp.
Catalent Maryland IncHarmans, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Wei Wang2 shared
Priscilla M Pastrana2 shared
Carla A Lorenzo1 shared
Guo-Chiuan Hung1 shared
Sharmila Shrestha1 shared
Kinjal S Patel1 shared
Prajakta A Varadkar1 shared
Donald B Ertel1 shared
Jianyang Wang1 shared
Anna R Kwilas1 shared
Full investigator report
Get the verbatim findings behind Bo Liang's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site